Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
1(50.0%)
Phase 4
1(50.0%)
2Total
N/A(1)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07291726Withdrawn

Composite Dietary Antioxidant Index and Metabolic Health in Overweight/Obesity in U.S. Adults

Role: lead

NCT06188195Not ApplicableRecruiting

Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS

Role: collaborator

NCT05647850Unknown

Optimization and Clinical Study of Early Prediction Model for Neonatal Acute Respiratory Distress Syndrome

Role: lead

NCT05265507Phase 4Unknown

Comparison of Postoperative Anti-nausea and Vomiting Effect Between Glycopyrronium and Ondansetron

Role: collaborator

All 4 trials loaded